HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jason D Morrow Selected Research

indomethacin phenethylamide

8/2005Inhibition of cyclooxygenase with indomethacin phenethylamide reduces atherosclerosis in apoE-null mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jason D Morrow Research Topics

Disease

25Inflammation (Inflammations)
09/2009 - 04/2002
18Neoplasms (Cancer)
11/2009 - 01/2002
18Atherosclerosis
10/2009 - 01/2002
8Cardiovascular Diseases (Cardiovascular Disease)
01/2012 - 01/2003
8Alzheimer Disease (Alzheimer's Disease)
05/2008 - 03/2002
7Neurodegenerative Diseases (Neurodegenerative Disease)
10/2009 - 02/2003
6Hypertension (High Blood Pressure)
08/2006 - 07/2002
5Lung Neoplasms (Lung Cancer)
03/2009 - 01/2003
5Colorectal Neoplasms (Colorectal Cancer)
11/2006 - 09/2002
4Disease Progression
11/2009 - 02/2003
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2009 - 09/2005
4Obesity
08/2008 - 03/2003
4Hypercholesterolemia
11/2007 - 04/2005
4Hyperlipidemias (Hyperlipidemia)
02/2007 - 03/2003
3Stroke (Strokes)
11/2009 - 06/2002
3Pneumonia (Pneumonitis)
09/2009 - 05/2002
3Carcinogenesis
04/2009 - 04/2003
3Hemolytic Anemia
11/2005 - 10/2002
2Insulin Resistance
12/2009 - 06/2002
2Ischemia
11/2009 - 01/2008
2Ischemic Stroke
11/2009 - 01/2008
2Squamous Cell Carcinoma of Head and Neck
11/2009 - 08/2005
2Infections
01/2009 - 08/2002
2Ulcer
01/2009 - 06/2008
2Vitamin E Deficiency
03/2008 - 12/2004
2Dehydration (Water Stress)
10/2007 - 09/2002
2Ovarian Epithelial Carcinoma
06/2007 - 05/2005
2Endotoxemia
11/2006 - 08/2004
2Polyps
11/2006 - 06/2004
2Adenoma (Adenomas)
11/2006 - 06/2004
2Carcinoma (Carcinomatosis)
11/2006 - 07/2004
2Lung Injury
06/2006 - 01/2006
2Lung Diseases (Lung Disease)
06/2006 - 12/2002
2Thrombosis (Thrombus)
01/2006 - 09/2003
2Respiratory Hypersensitivity
12/2005 - 04/2002
2Eosinophilia
12/2005 - 01/2005

Drug/Important Bio-Agent (IBA)

17ProstaglandinsIBA
11/2009 - 09/2002
17F2-Isoprostanes (F2 Isoprostanes)IBA
09/2009 - 06/2002
15Biomarkers (Surrogate Marker)IBA
02/2008 - 06/2002
13Free RadicalsIBA
10/2009 - 01/2002
12Oxidants (Oxidizing Agents)IBA
05/2009 - 08/2002
12Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2009 - 04/2003
9LipidsIBA
11/2011 - 01/2002
9Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
11/2009 - 04/2002
9Celecoxib (Celebrex)FDA Link
03/2009 - 09/2003
8Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
11/2009 - 04/2002
8AntioxidantsIBA
04/2008 - 02/2002
77- hydroxy- 5,11- dioxotetranorprostane- 1,16- dioic acidIBA
11/2009 - 11/2004
7Proteins (Proteins, Gene)FDA Link
03/2009 - 01/2002
7IsoprostanesIBA
09/2007 - 09/2002
6Prostaglandins EIBA
11/2009 - 03/2003
6Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2008 - 09/2003
5Fish OilsIBA
12/2009 - 07/2007
5Vitamin EFDA LinkGeneric
01/2009 - 08/2004
5Dinoprostone (PGE2)FDA Link
11/2006 - 07/2004
5Cyclooxygenase 1IBA
01/2006 - 04/2002
4CytokinesIBA
09/2009 - 01/2005
4Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2009 - 03/2002
4alpha-TocopherolFDA Link
01/2009 - 02/2004
4LDL Receptors (LDL Receptor)IBA
02/2007 - 04/2002
4Epoprostenol (Prostacyclin)FDA LinkGeneric
01/2007 - 09/2003
3Reactive Oxygen Species (Oxygen Radicals)IBA
11/2009 - 11/2005
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2009 - 10/2005
3Docosahexaenoic AcidsIBA
09/2009 - 05/2002
3Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
09/2009 - 10/2007
3Cyclooxygenase InhibitorsIBA
01/2009 - 03/2003
3EicosanoidsIBA
01/2009 - 09/2002
3VitaminsIBA
08/2008 - 09/2003
3C-Reactive ProteinIBA
02/2008 - 09/2003
3CholesterolIBA
07/2007 - 09/2003
3ThromboxanesIBA
01/2007 - 04/2003
3rofecoxib (Vioxx)FDA Link
08/2006 - 04/2002
3Apolipoproteins E (ApoE)IBA
01/2006 - 08/2005
3AllergensIBA
12/2005 - 04/2002
3Interleukin-13IBA
12/2005 - 04/2002
3Pharmaceutical PreparationsIBA
11/2005 - 03/2003
3cyclopentenoneIBA
10/2005 - 09/2002
3Indomethacin (Indometacin)FDA LinkGeneric
09/2005 - 04/2002
3oxidized low density lipoproteinIBA
01/2004 - 06/2002
2Neuroprotective AgentsIBA
11/2009 - 06/2009
2CreatinineIBA
11/2009 - 04/2009
2Eicosapentaenoic AcidIBA
09/2009 - 10/2007
2OvalbuminIBA
09/2009 - 04/2002
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
05/2009 - 05/2008
2Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
04/2009 - 12/2005
2AcidsIBA
05/2008 - 01/2008
2Interleukin-6 (Interleukin 6)IBA
02/2008 - 04/2005
2Arachidonic Acid (Vitamin F)IBA
09/2007 - 06/2006
2SC 560IBA
06/2007 - 05/2005
2AngiotensinsIBA
12/2006 - 10/2003
2EnzymesIBA
11/2006 - 03/2004
2Biological ProductsIBA
06/2006 - 01/2005
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
06/2006 - 01/2006
2Cimetidine (Biomet)FDA LinkGeneric
06/2006 - 01/2006
2ApolipoproteinsIBA
01/2006 - 09/2005
2Interleukin-5 (Interleukin 5)IBA
12/2005 - 01/2005
2Glucose (Dextrose)FDA LinkGeneric
09/2005 - 06/2004

Therapy/Procedure

10Therapeutics
05/2009 - 08/2002
3Art Therapy
01/2012 - 05/2009
2Aftercare (After-Treatment)
11/2006 - 09/2003